$9.72
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Country

US

CEO

Mr. Emmanuel Ligner

IPO date

2019

Employees

13,500

ISIN

US05352A1007

Key stats

Open

$9.59

Volume

8.27M

Market cap

$6.41B

Prev. close

$9.39

Impl / hst vl

-

Open interest

$0.00

$9.53

Day’s Range

$9.89

$7.27

52W Range

$12.90

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
0.81
P/B
0.95
Current ratio
1.76
Debt / Equity
0.63
ROE
-9.59%
Gross margin
31.66%
Income growth
-17.37%
FCF growth
-78.50

Analysts estimates

Consensus rating
Hold

The average rating from top 15 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$10.17
The top 20 analysts forecasts that 12-month price may increase by 4.68%, with a low of $7.07 and a high of $19.95
$7.07
Low
$10.17
Avg
$19.95
High
Current price

Earnings

Q1 ‘26 revenue
$1.58B
Q1 ‘26 net income
$43.30M
Revenue
Net income
Previous EPS
$0.22
Estimate EPS
$0.16
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply